PCOS Root Causes: Functional Testing & Hormone Balance

The PCOS Puzzle: Using Functional Testing to Address Root Causes and Restore Balance

Author: Rohan Smith | Functional Medicine Practitioner | Adelaide, SA

Quick Answer

Polycystic Ovary Syndrome (PCOS) is a metabolic-endocrine condition driven by insulin resistance, chronic low-grade inflammation, and disrupted androgen regulation. A functional medicine approach uses targeted testing, including the DUTCH Complete hormone panel, to identify individual drivers such as hyperinsulinaemia, elevated cortisol, and impaired oestrogen metabolism, then applies personalised nutrition and lifestyle strategies to restore hormonal balance.

This may involve targeted lifestyle interventions alongside functional testing to assess insulin signalling, androgen activity, cortisol patterns, and hormone metabolism (4–6).

At a Glance

  • PCOS affects up to 13% of women of reproductive age and is recognised as a multisystem metabolic-endocrine condition, not solely a reproductive disorder (1,2).
  • Insulin resistance is estimated to affect about 50% to 70% of women with PCOS and may drive compensatory hyperinsulinaemia and excess ovarian androgen production (3,7).
  • Women with PCOS tend to have higher C-reactive protein, a sign of chronic low-grade inflammation that may contribute to the condition, and gut microbiome disruption may also play a part (8,9).
  • The DUTCH Complete test measures sex hormone metabolites, diurnal cortisol patterns, and androgen clearance pathways to inform personalised management strategies. A small study, not specific to PCOS, found dried urine collections agreed well with 24-hour urine for reproductive hormones and their metabolites (10).
  • Myo-inositol supplementation may improve insulin sensitivity in women with PCOS, according to a meta-analysis of randomised controlled trials and related work (14,15).

PCOS: More Than Just a Reproductive Condition

PCOS is one of the most common endocrine disorders in women of reproductive age, with prevalence estimates ranging from 8% to 13% depending on the diagnostic criteria applied (1). The condition is typically diagnosed based on a combination of ovulatory dysfunction, hyperandrogenism, and polycystic ovarian morphology using the Rotterdam criteria. Increasingly, research by Andrea Dunaif and others suggests that PCOS is best understood as a multisystem metabolic-endocrine condition rather than a purely gynaecological disorder (2,3).

Many women with PCOS experience symptoms beyond the reproductive system, including persistent fatigue, difficulty managing weight, mood disturbances, and sugar cravings. These features often reflect underlying disturbances in insulin signalling, inflammatory pathways, and hypothalamic-pituitary-adrenal (HPA) axis dysregulation, which are commonly explored in patients presenting with chronic fatigue.

Key Mechanisms Involved in PCOS

Mechanism Description Key References
Insulin resistance Reduced cellular responsiveness to insulin can lead to compensatory hyperinsulinaemia, which may stimulate excess ovarian androgen production via cytochrome P450c17 enzyme activity and disrupt ovulation (3,7)
Chronic low-grade inflammation C-reactive protein (CRP) is elevated in PCOS independent of obesity, although pooled results for interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-alpha) have not shown a clear difference. This low-grade inflammation may contribute to the condition, and a small trial suggests it may be influenced by gut health and the gut microbiome (8,9)
Hormonal imbalance Elevated androgens (testosterone, DHEA-S, androstenedione) and altered luteinising hormone (LH) to follicle-stimulating hormone (FSH) ratios can interfere with normal follicular development and ovulation (2)

How Functional Testing Can Support a Root-Cause Approach

Functional medicine testing provides additional physiological context alongside standard medical assessment, including fasting insulin, sex hormone-binding globulin (SHBG), and lipid panels commonly ordered by endocrinologists and gynaecologists. These tools are not diagnostic for PCOS, but may offer useful insight into patterns that influence symptom severity, metabolic health, and hormonal regulation.

DUTCH Hormone Testing

The Dried Urine Test for Comprehensive Hormones (DUTCH), developed by Precision Analytical, evaluates sex hormones, their metabolites, and diurnal cortisol patterns via dried urine samples collected over a 24-hour period. In women with PCOS, DUTCH testing may help explore:

Parameter Assessed Clinical Relevance to PCOS
Cortisol rhythm (free cortisol and cortisone) May reveal HPA axis dysregulation contributing to adrenal androgen excess
Oestrogen metabolism (2-OH, 4-OH, 16-OH pathways) Can indicate methylation and detoxification capacity via COMT enzyme activity
Relative progesterone output May reflect anovulatory cycles and luteal phase insufficiency
Androgen production and clearance (5-alpha reductase activity) Helps distinguish ovarian from adrenal sources of excess androgens

When clinically appropriate, comprehensive hormone testing such as the DUTCH Complete test can be used to support a personalised care plan. All results must be interpreted within the broader clinical picture and are used to inform care strategies rather than replace conventional diagnostic criteria. Background reading on this kind of testing includes a small study of dried urine collection for reproductive hormones, a review of how androgens are measured in women, and a review of the CYP17A1 enzyme involved in sex steroid production (10–12).

A Multi-Layered Strategy for Managing PCOS

Research published in the Endocrine Society’s guidelines and the 2023 International Evidence-Based PCOS Guideline led by Helena Teede confirms that effective PCOS management typically requires a personalised and multi-factorial strategy addressing metabolic, inflammatory, and lifestyle contributors concurrently (2,6).

Nutrition Support

Dietary Strategy Mechanism of Action
Low-glycaemic dietary patterns Insulin resistance probably contributes to androgen excess in PCOS (7), so eating in a way that supports stable blood glucose levels may help reduce insulin demand
Anti-inflammatory foods Diets rich in omega-3 fatty acids (EPA and DHA) and fibre may help calm inflammation. In a small trial of 25 women with PCOS and no diet-free comparison group, inflammatory state improved on a high-fibre diet that included prebiotics and traditional Chinese medicinal foods, both in the 14 women on the diet alone and in the 11 who also took acarbose (8,13)
Reducing ultra-processed foods Excess refined carbohydrates, seed oils, and added sugars may exacerbate insulin resistance and metabolic stress

Nutrient Support (When Clinically Indicated)

Nutrient Evidence Summary
Myo-inositol May support insulin sensitivity in some women with PCOS, according to a meta-analysis of randomised controlled trials by Unfer et al. and related work (14,15)
Omega-3 fatty acids (EPA/DHA) Anti-inflammatory effects have been reviewed by Simopoulos, and a meta-analysis of trials in PCOS found improvements in insulin resistance, cholesterol and triglycerides (13,16)
Magnesium Intracellular magnesium plays a key role in insulin action and insulin-mediated glucose uptake, and low levels have been linked with worse insulin resistance, mainly in studies of type 2 diabetes (17)
Vitamin D Low 25-hydroxyvitamin D status is commonly observed in PCOS and may be associated with metabolic and reproductive features, as reported by Thomson et al. (18,19)

Lifestyle Interventions

  • Regular physical activity: Both resistance training and aerobic exercise may improve insulin sensitivity and cardiometabolic health markers, including HOMA-IR and waist circumference (20).
  • Stress regulation: Mind-body practices such as yoga, meditation, and diaphragmatic breathing can support cortisol balance and neuroendocrine function, which may overlap with thyroid and stress-related patterns discussed in thyroid health.
  • Sleep quality: Consistent, restorative sleep (7–9 hours) is essential for melatonin production, hormonal regulation, and glucose control.

When to Consider Functional Assessment

Functional assessment may be appropriate for women with PCOS who continue to experience symptoms despite standard interventions, or where metabolic features such as insulin resistance, fatigue, or HPA axis dysfunction are prominent. Testing should always be guided and interpreted by a qualified practitioner such as a clinical nutritionist or integrative medicine practitioner with experience in hormonal health.

Next Steps

  1. Assess your metabolic foundations: Review your dietary patterns, blood glucose stability, and insulin sensitivity markers (fasting insulin, HOMA-IR, HbA1c) with your practitioner to identify key metabolic drivers.
  2. Consider comprehensive hormone testing: A DUTCH Complete or similar panel can provide insight into cortisol rhythms, androgen metabolism, and oestrogen clearance pathways relevant to PCOS.
  3. Build a personalised strategy: Work with a qualified functional medicine practitioner to integrate nutrition, lifestyle, and targeted support based on your individual test results and symptom patterns.

Frequently Asked Questions

What are the main underlying drivers of PCOS beyond reproductive symptoms?
PCOS is increasingly understood as a multisystem metabolic-endocrine condition. Common underlying drivers include insulin resistance, low-grade chronic inflammation, and disrupted stress and sex hormone regulation. These factors can influence ovulation, androgen production, energy levels, mood, and long-term cardiometabolic risk, extending well beyond reproductive health alone.
How can functional testing support a personalised approach to PCOS?
Functional testing does not diagnose PCOS, but it may help identify physiological patterns that influence symptom severity and metabolic health. Tests such as the DUTCH Complete hormone panel can provide insight into cortisol rhythms, androgen activity, and hormone metabolism. When interpreted alongside clinical assessment, these findings may help guide individualised nutrition, lifestyle, and support strategies.
Can PCOS symptoms improve without medication?
While PCOS is considered a chronic condition, many symptoms and associated metabolic risk factors may improve with appropriate lifestyle and nutritional support. Strategies that address insulin sensitivity, inflammation, stress regulation, sleep quality, and overall metabolic health are commonly used alongside, or sometimes instead of, medication depending on individual circumstances and clinical guidance.

Key Insights

  • PCOS is a multisystem metabolic-endocrine condition, not solely a reproductive disorder
  • Insulin resistance and chronic low-grade inflammation play central roles in driving PCOS symptoms
  • Functional testing such as DUTCH hormone panels can support personalised care when used appropriately
  • Long-term management focuses on metabolic and hormonal resilience through nutrition, lifestyle, and targeted support

Citable Takeaways

  1. PCOS affects up to 13% of women of reproductive age and is classified as a multisystem metabolic-endocrine condition according to the International Evidence-Based PCOS Guideline led by Teede et al. (2).
  2. Insulin resistance is estimated to affect about 50% to 70% of women with PCOS and probably contributes to hyperandrogenism, according to Legro et al. (7). It may drive compensatory hyperinsulinaemia that stimulates excess ovarian androgen production, as described by Dunaif (3).
  3. Circulating CRP is elevated in women with PCOS independent of obesity, which points to chronic low-grade inflammation that may underpin the condition, while pooled results for IL-6 and TNF-alpha showed no clear difference, according to a meta-analysis by Escobar-Morreale et al. (9).
  4. Myo-inositol supplementation may lower fasting insulin and improve insulin resistance in women with PCOS, according to a meta-analysis of randomised controlled trials by Unfer et al. (14).
  5. The DUTCH Complete test evaluates sex hormone metabolites, diurnal cortisol patterns, and androgen clearance pathways, providing physiological context for personalised PCOS management strategies. In a small study not specific to PCOS, Newman et al. (10) found dried urine collections agreed well with 24-hour urine for reproductive hormones and metabolites.
  6. Both resistance training and aerobic exercise may improve insulin sensitivity and cardiometabolic health markers in women with PCOS, as reported in a systematic review by Harrison et al. (20).

Take a Root-Cause Approach to PCOS

If you are seeking a personalised, evidence-informed approach to PCOS care that goes beyond symptom suppression, functional medicine assessment can help identify the metabolic and hormonal drivers unique to you. At Elemental Health and Nutrition, we integrate comprehensive testing with targeted nutrition and lifestyle strategies to support long-term hormonal balance.

Book an Appointment

References

  1. Azziz R et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016 Apr 28;2:16057. https://doi.org/10.1038/nrdp.2016.57
  2. Teede HJ et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018 Sep 1;33(9):1602-1618. https://doi.org/10.1093/humrep/dey256
  3. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997 Dec;18(6):774-800. https://doi.org/10.1210/edrv.18.6.0318
  4. Diamanti-Kandarakis E et al. Pathophysiology and types of dyslipidemia in PCOS. Trends in Endocrinology & Metabolism. 2007;18(7):280-285. https://doi.org/10.1016/j.tem.2007.07.004
  5. Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016 Oct;37(5):467-520. https://doi.org/10.1210/er.2015-1104
  6. Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018 May;14(5):270-284. https://doi.org/10.1038/nrendo.2018.24
  7. Legro RS et al. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv. 2004;59(2):141-54. https://doi.org/10.1097/01.ogx.0000109523.25076.e2
  8. Wang X et al. High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota. Front Endocrinol (Lausanne). 2021;12:806331. https://doi.org/10.3389/fendo.2021.806331
  9. Escobar-Morreale HF et al. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011;95(3):1048-58.e1-2. https://doi.org/10.1016/j.fertnstert.2010.11.036
  10. Newman M, Curran DA. Reliability of a dried urine test for comprehensive assessment of urine hormones and metabolites. BMC Chem. 2021;15(1):18. https://doi.org/10.1186/s13065-021-00744-3
  11. Stanczyk F. Measurement of Androgens in Women. Seminars in Reproductive Medicine. 2006;24(2):078-085. https://doi.org/10.1055/s-2006-939566
  12. Auchus RJ. Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):71-78. https://doi.org/10.1016/j.jsbmb.2016.02.002
  13. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002 Dec;21(6):495-505. https://doi.org/10.1080/07315724.2002.10719248
  14. Unfer V et al. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017;6(8):647-658. https://doi.org/10.1530/ec-17-0243
  15. Pizzo A et al. Myo-inositol in the treatment of polycystic ovary syndrome. Eur Rev Med Pharmacol Sci. 2014;18(13):1896-903. https://pubmed.ncbi.nlm.nih.gov/25010644/
  16. Yang K et al. Effectiveness of Omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2018;16(1):27. https://doi.org/10.1186/s12958-018-0346-x
  17. Barbagallo M, Dominguez LJ. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys. 2007;458(1):40-7. https://doi.org/10.1016/j.abb.2006.05.007
  18. Wehr E et al. Association of vitamin D status with serum androgen levels in men. Clinical Endocrinology. 2010;73(2):243-248. https://doi.org/10.1111/j.1365-2265.2009.03777.x
  19. Thomson RL et al. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012;77(3):343-50. https://doi.org/10.1111/j.1365-2265.2012.04434.x
  20. Harrison CL et al. Exercise therapy in polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2011 Mar-Apr;17(2):171-83. https://doi.org/10.1093/humupd/dmq045
  21. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5(7):374-81. https://doi.org/10.1038/nrendo.2009.106

Ready to find answers?

Stop surviving. Start recovering.

Similar Posts